Combining alcohol interventions with tobacco addictions treatment in primary care-the COMBAT study: a pragmatic cluster randomized trial

Implementation Science : IS
Nadia MinianPeter L Selby

Abstract

Tobacco and alcohol use present multiplicative risk for aerodigestive cancers. Reducing alcohol consumption improves smoking cessation outcomes and reduces cancer risk. Risky alcohol consumption and smoking are often treated separately despite concurrent treatment potentially leading to better outcomes for each. However, no rapidly scalable program exists for combined interventions in primary care clinics spread across wide geographic areas. This cluster randomized trial aims to report on the effects of a novel clinical decision support system (CDSS) on intervention rates by primary care practitioners addressing risky alcohol use in a smoking cessation program. We will be implementing a clinical decision support system (CDSS) in 221 primary care sites participating in the Smoking Treatment for Ontario Patients (STOP) program across Ontario, Canada. Sites will be blindly allocated to one of two clinical decision support systems guiding practitioners to provide a risky alcohol use intervention to smokers attempting to quit using nicotine replacement therapy (NRT). Risky alcohol use is defined as drinking above the Canadian Cancer Society's low-risk drinking guidelines. Primary analysis will measure the proportion of risky drinker...Continue Reading

References

Mar 1, 1993·Addiction·T H BienJ S Tonigan
May 17, 2000·Drug and Alcohol Dependence·D A Dawson
Dec 23, 2004·Journal of Consulting and Clinical Psychology·Judith J ProchaskaSharon M Hall
Mar 10, 2005·JAMA : the Journal of the American Medical Association·Amit X GargR Brian Haynes
May 11, 2005·Archives of Internal Medicine·Nicolas BertholetBernard Burnand
Jan 31, 2006·Alcoholism, Clinical and Experimental Research·Dieter J MeyerhoffSara Jo Nixon
Mar 1, 2006·Preventive Medicine·Arnaud ChioleroJacques Cornuz
Sep 5, 2006·Drug and Alcohol Dependence·Timothy C DurazzoDieter J Meyerhoff
Dec 14, 2007·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Thomas F BaborJeremy Bray
Jul 16, 2008·Pharmaceutical Research·Preetha AnandBharat B Aggarwal
Jun 6, 2009·Drug and Alcohol Review·Eileen F S KanerNick Heather
Jun 21, 2011·Oral Oncology·Devasena AnantharamanGary J Macfarlane
Aug 10, 2011·Implementation Science : IS·Pavel S RoshanovUNKNOWN CCDSS Systematic Review Team
Jun 4, 2013·The Cochrane Database of Systematic Reviews·Lindsay F SteadTim Lancaster
May 10, 2015·BMJ : British Medical Journal·Kirsty LoudonMerrick Zwarenstein

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03108144

Software Mentioned

Stata
CDSS
COMBAT
PRECIS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.